Telix Pharmaceuticals (TLX) Shares Outstanding (Diluted) (2023 - 2025)

Telix Pharmaceuticals (TLX) Shares Outstanding (Diluted) (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 52.24 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 680.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 66.36 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Telix Pharmaceuticals 3.46 Bn 3.31 Bn - 337.88 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 337.88 Mn
Dec 31, 2024 345.19 Mn
Dec 31, 2023 323.71 Mn